Cargando…

Undercarboxylated osteocalcin as a biomarker of subclinical atherosclerosis in non-dialysis patients with chronic kidney disease

BACKGROUND: Studies in recent years have shown that undercarboxylated osteocalcin (uOC) not only maintains bone mineralization, but is also involved in the regulation of atherosclerosis. However, a correlation between uOC and carotid atherosclerosis in non-dialysis patients with chronic kidney disea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Minfang, Ni, Zhaohui, Zhou, Wenyan, Qian, Jiaqi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573290/ https://www.ncbi.nlm.nih.gov/pubmed/26381729 http://dx.doi.org/10.1186/s12929-015-0183-6

Ejemplares similares

Diagnostic Utility of Osteocalcin, Undercarboxylated Osteocalcin, and Alkaline Phosphatase for Osteoporosis in Premenopausal and Postmenopausal Women
por: Atalay, Sacide, et al.
Publicado: (2012)

Correlations Between Changes in Undercarboxylated Osteocalcin and Muscle Function in Hypoparathyroidism
por: Harslof, Torben, et al.
Publicado: (2016)

Carboxylated and undercarboxylated osteocalcin in metabolic complications of human obesity and prediabetes
por: Razny, Urszula, et al.
Publicado: (2016)

Undercarboxylated osteocalcin correlates with insulin secretion in Japanese individuals with diabetes
por: Funakoshi, Shogo, et al.
Publicado: (2020)

Undercarboxylated osteocalcin can predict insulin secretion ability in type 2 diabetes
por: Takashi, Yuichi, et al.
Publicado: (2017)

Undercarboxylated osteocalcin inhibits the early differentiation of osteoclast mediated by Gprc6a
por: Wang, Hailong, et al.
Publicado: (2021)

Diversity of Gut Microbiota Affecting Serum Level of Undercarboxylated Osteocalcin in Patients with Crohn’s Disease
por: Wagatsuma, Kohei, et al.
Publicado: (2019)

Undercarboxylated, But Not Carboxylated, Osteocalcin Suppresses TNF-α–Induced Inflammatory Signaling Pathway in Myoblasts
por: Park, Danbi, et al.
Publicado: (2022)

Bone Turnover Markers Including Undercarboxylated Osteocalcin Are Associated With Mortality Risk in Older Men
por: Robertson, Courtney L, et al.
Publicado: (2022)

Association between undercarboxylated osteocalcin, bone mineral density, and metabolic parameters in postmenopausal women
por: Zanatta, Leila C. B., et al.
Publicado: (2018)

Association between Osteocalcin, Metabolic Syndrome, and Cardiovascular Risk Factors: Role of Total and Undercarboxylated Osteocalcin in Patients with Type 2 Diabetes
por: Alfadda, Assim A., et al.
Publicado: (2013)

Relationship between serum osteocalcin/undercarboxylated osteocalcin and type 2 diabetes: a systematic review/meta-analysis study protocol
por: Liu, Yihui, et al.
Publicado: (2019)

Analysis of serum undercarboxylated osteocalcin level in rats with type 2 diabetes mellitus and the correlation with cognitive impairment
por: Gu, Peng-Ying, et al.
Publicado: (2017)

Correction: Relationship between serum osteocalcin/undercarboxylated osteocalcin and type 2 diabetes: a systematic review/meta-analysis study protocol
Publicado: (2019)

Correlation of Undercarboxylated Osteocalcin (ucOC) Concentration and Bone Density with Age in Healthy Korean Women
por: Kim, Sang-Man, et al.
Publicado: (2010)

Circulating Undercarboxylated Osteocalcin as Estimator of Cardiovascular and Type 2 Diabetes Risk in Metabolic Syndrome Patients
por: Riquelme-Gallego, Blanca, et al.
Publicado: (2020)

Undercarboxylated osteocalcin has no adverse effect on endothelial function in rabbit aorta or human vascular cells
por: Tacey, Alexander, et al.
Publicado: (2020)

Undercarboxylated osteocalcin reverts insulin resistance induced by endoplasmic reticulum stress in human umbilical vein endothelial cells
por: Guo, Qinyue, et al.
Publicado: (2017)

Undercarboxylated Osteocalcin: Experimental and Human Evidence for a Role in Glucose Homeostasis and Muscle Regulation of Insulin Sensitivity
por: Lin, Xuzhu, et al.
Publicado: (2018)

Effect of Weight Loss, Exercise, or Both on Undercarboxylated Osteocalcin and Insulin Secretion in Frail, Obese Older Adults
por: Colleluori, Georgia, et al.
Publicado: (2017)

Association of Vitamin K Insufficiency as Evaluated by Serum Undercarboxylated Osteocalcin With Frailty in Community-Dwelling Older Adults
por: Azuma, Kotaro, et al.
Publicado: (2022)

Serum levels of undercarboxylated osteocalcin are related to cardiovascular risk factors in patients with type 2 diabetes mellitus and healthy subjects
por: Sanchez-Enriquez, Sergio, et al.
Publicado: (2017)

Undercarboxylated osteocalcin does not correlate with insulin resistance as assessed by euglycemic hyperinsulinemic clamp technique in patients with type 2 diabetes mellitus
por: Mori, Katsuhito, et al.
Publicado: (2012)

Undercarboxylated Osteocalcin: A Promising Target for Early Diagnosis of Cardiovascular and Glycemic Disorders in Patients with Metabolic Syndrome: A Pilot Study
por: Riquelme-Gallego, Blanca, et al.
Publicado: (2022)

A Single Dose of Prednisolone as a Modulator of Undercarboxylated Osteocalcin and Insulin Sensitivity Post-Exercise in Healthy Young Men: A Study Protocol
por: Levinger, Itamar, et al.
Publicado: (2016)

Undercarboxylated osteocalcin is associated with vascular function in female older adults but does not influence vascular function in male rabbit carotid artery ex vivo
por: Tacey, Alexander, et al.
Publicado: (2020)

Undercarboxylated Osteocalcin and Its Associations With Bone Mineral Density, Bone Turnover Markers, and Prevalence of Osteopenia and Osteoporosis in Chinese Population: A Cross-Sectional Study
por: Xu, Yang, et al.
Publicado: (2022)

Klotho as a biomarker of subclinical atherosclerosis in patients with moderate to severe chronic kidney disease
por: Donate-Correa, Javier, et al.
Publicado: (2021)

Osteocalcin association with vascular function in chronic kidney disease
por: Guo, Xinru, et al.
Publicado: (2022)

A Nomogram for Identifying Subclinical Atherosclerosis in Chronic Kidney Disease
por: Xiong, Jiachuan, et al.
Publicado: (2021)

Biomarkers of subclinical atherosclerosis in patients with psoriasis
por: Kaiser, Hannah, et al.
Publicado: (2021)

Association of Serum Osteocalcin with Insulin Resistance and Coronary Atherosclerosis
por: Kang, Jee-Hyun
Publicado: (2016)

Effect of supplementation with vitamins D3 and K2 on undercarboxylated osteocalcin and insulin serum levels in patients with type 2 diabetes mellitus: a randomized, double-blind, clinical trial
por: Aguayo-Ruiz, J. I., et al.
Publicado: (2020)

Subclinical cardiovascular disease markers and vitamin D deficiency in non-dialysis chronic kidney disease patients
por: Căpuşa, Cristina, et al.
Publicado: (2016)

Subclinical Atherosclerosis in Patients with Chronic Non-Dialytic Renal Disease
por: Borges, Wagner Ramos, et al.
Publicado: (2015)

Biomarkers of Subclinical Atherosclerosis in Patients with Autoimmune Disorders
por: Profumo, Elisabetta, et al.
Publicado: (2012)

Biomarkers of subclinical atherosclerosis in patients with psoriatic arthritis
por: Peluso, Rosario, et al.
Publicado: (2019)

Vitamin K Supplement Along with Vitamin D and Calcium Reduced Serum Concentration of Undercarboxylated Osteocalcin While Increasing Bone Mineral Density in Korean Postmenopausal Women over Sixty-Years-Old
por: Je, Sang Hyeon, et al.
Publicado: (2011)

Potential Role for Osteocalcin in the Development of Atherosclerosis and Blood Vessel Disease
por: Tacey, Alexander, et al.
Publicado: (2018)

Matrix Metalloproteinases and Subclinical Atherosclerosis in Chronic Kidney Disease: A Systematic Review
por: Kousios, Andreas, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gqp9jpvnot2hhfu54sko1199d0